Medical device company Penumbra (NYSE: PEN) will be reporting results this Wednesday after the bell. Here’s what investors should know.
Penumbra beat analysts’ revenue expectations by 3.7% last quarter, reporting revenues of $339.5 million, up 13.4% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ constant currency revenue estimates and a solid beat of analysts’ revenue estimates.
Is Penumbra a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Penumbra’s revenue to grow 13.1% year on year to $340.4 million, improving from the 11.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.92 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Penumbra has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.4% on average.
Looking at Penumbra’s peers in the healthcare equipment and supplies segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Merit Medical Systems delivered year-on-year revenue growth of 13%, beating analysts’ expectations by 3.2%, and Intuitive Surgical reported revenues up 22.9%, topping estimates by 3%. Merit Medical Systems traded up 5.3% following the results while Intuitive Surgical was also up 13.9%.
Read our full analysis of Merit Medical Systems’s results here and Intuitive Surgical’s results here.
Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Penumbra is down 11.5% during the same time and is heading into earnings with an average analyst price target of $304.53 (compared to the current share price of $226.19).
P.S. In tech investing, "Gorillas" are the rare companies that dominate their markets—like Microsoft and Apple did decades ago. Today, the next Gorilla is emerging in AI-powered enterprise software. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
